Gilead Sciences (GILD)

R&D Expenses

$6.07B

TTM · Period ending: · USD

GILD logo

GILD R&D Expenses

Latest reported$6.07B
GILD TTM R&D Expenses ($0.00 → $6.07B)
High-resolution chart · PNG

GILD r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Gilead Sciences R&D Expenses — Trailing twelve months (TTM) (USD)
Period endingR&D Expenses (USD)
173,484,000
156,866,000
131,966,000
120,038,000
112,606,000
112,399,000
111,751,000
101,851,000
102,751,000
93,798,000
87,100,000
85,900,000
70,900,000
67,300,000
59,200,000
50,000,000
47,600,000
43,500,000
42,000,000
39,300,000
35,600,000
33,100,000
31,900,000
23,700,000
23,300,000
15,200,000
7,100,000
7,100,000
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.